J Korean Ophthalmol Soc.  2005 Sep;46(9):1586-1591.

Triamcinolone Regurgitation into Anterior Chamber after Intravitreal Triamcinolone Injection

Affiliations
  • 1Department of Ophthalmology, Cheil Eye Hospital, Daegu, Korea. drdugi@dreamwiz.com

Abstract

PURPOSE
To report triamcinolone regurgitation into the anterior chamber after intravitreal triamcinolone injection for macular edema. METHODS: A total of 402 eyes (432 cases) received intravitreal injection of triamcinolone acetonide for macular edema from November 2002 to December 2004. A retrospective review included the medical records of all patients who showed regurgitation into the anterior chamber after intravitreal triamcinolone injection. The clinical outcome and any complications were analyzed. RESULTS: Regurgitation was observed in 9 of 402 eyes (11 of 432 cases, 2.55%) after intravitreal triamcinolone acetonide injection. All were phakic eyes. Pseudohypopyon was observed during the follow-up period but resolved gradually without any significant complications. Intravitreal injection of triamcinolone acetonide results in increased visual acuity (p<0.01) and decreased macular thickness (p<0.01) after 2 weeks of injection. CONCLUSIONS: Triamcinolone particles that regurgitated into the anterior chamber gradually resolved without any significant complications. These can, however, mask symptoms of endophthalmitis and delay accurate diagnosis, so careful follow-up examination is imperaive.

Keyword

Intraocular pressure; Intravitreal injection; Macular edema; Pseudohypopyon; Triamcinolone acetonide

MeSH Terms

Anterior Chamber*
Diagnosis
Endophthalmitis
Follow-Up Studies
Humans
Intraocular Pressure
Intravitreal Injections
Macular Edema
Masks
Medical Records
Retrospective Studies
Triamcinolone Acetonide
Triamcinolone*
Visual Acuity
Triamcinolone
Triamcinolone Acetonide
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr